Registry of Toxic Effects of Chemical Substances (RTECS)
Cyclohexylamine
RTECS #
GX0700000CAS #
108-91-8Updated
September 201Molecular Weight
99.20Molecular Formula
C6H13NSynonyms
AminocyclohexaneAminohexahydrobenzene
Aniline, hexahydro-
Benzenamine, hexahydro-
CHA
Cyclohexanamine
Cyclohexylamine (ACGIH)
Hexahydroaniline
Hexahydrobenzenamine
Skin and Eye Irritation and References
| Route/Organism | Dose | Effect | Reference | 
|---|---|---|---|
| eye /rabbit | 50 µg/24H | severe | 85JCAE -,454,1986 | 
| eye /rabbit | 100 µL/5M | severe | NTIS** OTS0540890 | 
| skin /human | 125 mg/48H | severe | AMIHBC 5,311,1952 | 
| skin /rabbit | 2 mg/24H | severe | 85JCAE -,454,1986 | 
| skin /rabbit | 500 µL | severe | NTIS** OTS0540890 | 
Mutation Data and Reference
| System Test | Route/Organism/Tissue | Dose | Reference | 
|---|---|---|---|
| Cytogenetic Analysis | leukocyte/human | 10 µmol/L/5H | MUREAV 39,1,1976 | 
| Cytogenetic Analysis | intraperitoneal/rat | 5 mg/kg/5D-continuous | SCIEAS 165,1139,1969 | 
| Cytogenetic Analysis | fibroblast/hamster | 10 mg/L | MUREAV 39,1,1976 | 
| Cytogenetic Analysis | unreported route/domestic animal | 50 mg/kg | MUREAV 26,407,1974 | 
| Cytogenetic Analysis | kidney/mammal (species unspecified) | 50 mg/L/8H-continuous | FCTXAV 8,617,1970 | 
| DNA inhibition | HeLa cell/human | 100 µg/L | INHEAO 9,188,1971 | 
| Dominant Lethal Test | intraperitoneal/mouse | 500 mg/kg/5D- intermittent | MUREAV 14,126,1972 | 
| host-mediated assay | leukocyte/hamster | 450 mg/kg/3D-continuous | MUREAV 31,5,1975 | 
| morphological transform | embryo/hamster | 60 mg/L | AETODY 1,241,1980 | 
| specific locus test | intraperitoneal/mouse | 200 mg/kg | PCBRD2 109,339,1982 | 
Reproductive Effects Data and References
| Route/Organism | Dose | Effect | Reference | 
|---|---|---|---|
| intraperitoneal/rat | 300 mg/kg (1D male) | Reproductive: Effects on fertility: Other measures of fertility | FCTXAV 10,29,1972 | 
| intraperitoneal/rat | 100 mg/kg (1D male) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | FCTXAV 10,29,1972 | 
| intraperitoneal/mouse | 61 mg/kg (11D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | TJADAB 4,141,1971 | 
| intraperitoneal/mouse | 77 mg/kg (11D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | TJADAB 4,141,1971 | 
| intraperitoneal/mouse | 200 mg/kg (10D pregnant) | Reproductive: Effects on fertility: Other measures of fertility | PCBRD2 109,339,1982 | 
| oral/mouse | 600 mg/kg (6-11D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetal death  | SEIJBO 11,51,1971 | 
| oral/mouse | 120 mg/kg (6-11D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | SEIJBO 11,51,1971 | 
| oral/Dog | 14 gm/kg (8W male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | FCTXAV 19,291,1981 | 
| oral/Dog | 15750 mg/kg (9W male) | Reproductive: Paternal effects: Testes, epididymis, sperm duct | FCTXAV 19,291,1981 | 
| oral/rat | 5600 mg/kg (4W male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | FCTXAV 19,291,1981 | 
| parenteral/mouse | 250 mg/kg (5D male) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | AMESES 1,33,1970 | 
| unreported route/rat | 5 mg/kg (1D male) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | AMESES 1,25,1970 | 
Acute Toxicity Data and References
| Route/Organism | Dose | Effect | Reference | 
|---|---|---|---|
| inhalation/guinea pig | Lowest published lethal concentration: 1200 ppm/7H | Lung, Thorax, or Respiration: Other changes | IMSUAI 19,317,1950 | 
| inhalation/mouse | lethal concentration (50 percent kill): 1070 mg/m3 | Behavioral: Excitement Behavioral: Muscle contraction or spasticity  | GTPZAB 7(11),51,1963 | 
| inhalation/rabbit | Lowest published lethal concentration: 150 ppm/7H | IMSUAI 19,317,1950 | |
| inhalation/rat | lethal concentration (50 percent kill): 7500 mg/m3 | Behavioral: Excitement Behavioral: Muscle contraction or spasticity  | GTPZAB 7(11),51,1963 | 
| intraperitoneal/mammal (species unspecified) | lethal dose (50 percent kill): 200 mg/kg | Brain and Coverings: Other degenerative changes Vascular: Shock Liver: Other changes  | AMIHBC 5,311,1952 | 
| intraperitoneal/mouse | lethal dose (50 percent kill): 129 mg/kg | PCJOAU 22,469,1988 | |
| intraperitoneal/rat | lethal dose (50 percent kill): 300 mg/kg | Eye: Mydriasis (pupilliary dilation) Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea  | NYKZAU 65(1),53S,1969 | 
| intravenous/Dog | lethal dose (50 percent kill): 200 mg/kg | Behavioral: Convulsions or effect on seizure threshold | NYKZAU 65(1),53S,1969 | 
| intravenous/mouse | lethal dose (50 percent kill): 200 mg/kg | IPSTB3 3,93,1976 | |
| oral/mouse | lethal dose (50 percent kill): 224 mg/kg | 85GMAT -,41,1982 | |
| oral/rat | lethal dose (50 percent kill): 11 mg/kg | Behavioral: Food intake (animal) Lung, Thorax, or Respiration: Pulmonary emboli Gastrointestinal: Other changes  | NTIS** OTS0534836 | 
| parenteral/rabbit | lowest published lethal dose: 500 mg/kg | Behavioral: Convulsions or effect on seizure threshold | IECHAD 29,1247,1937 | 
| skin/rabbit | lethal dose (50 percent kill): 320 µL/kg | AIHAAP 30,470,1969 | |
| subcutaneous/mouse | lethal dose (50 percent kill): 1150 mg/kg | VOONAW 4,659,1958 | |
| unreported route/mouse | lethal dose (50 percent kill): 770 mg/kg | TXAPA9 14,654,1969 | 
Other Multiple Dose Data and References
| Route/Organism | Dose | Effect | Reference | 
|---|---|---|---|
| inhalation/rat | lowest published toxic concentration: 700 mg/m3/2H/9W- intermittent | Cardiac: Changes in heart weight Kidney, Ureter, and Bladder: Changes in bladder weight Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field  | GTPZAB 7(11),51,1963 | 
| inhalation/rat | lowest published toxic concentration: 100 mg/m3/4H/22W- intermittent | Kidney, Ureter, and Bladder: Changes in bladder weight Blood: Changes in cell count (unspecified) Nutritional and Gross Metabolic: Other changes  | GTPZAB 7(11),51,1963 | 
| oral/rat | lowest published toxic dose: 1200 mg/kg/3D- continuous | Behavioral: Food intake (animal) Nutritional and Gross Metabolic: Weight loss or decreased weight gain  | EXMPA6 52,155,1990 | 
| oral/rat | lowest published toxic dose: 2800 mg/kg/1W- continuous | Related to Chronic Data: Changes in testicular weight | EXMPA6 52,155,1990 | 
| oral/rat | lowest published toxic dose: 8400 mg/kg/3W- continuous | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Reproductive: Paternal effects: Testes, epididymis, sperm duct  | EXMPA6 52,155,1990 | 
| oral/rat | lowest published toxic dose: 35700 mg/kg/1Y- continuous | Liver: Other changes Kidney, Ureter, and Bladder: Other changes  | VOONAW 4,659,1958 | 
Reviews
| Organization | Standard | Reference | 
|---|---|---|
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 10 ppm | DTLVS* TLV/BEI,2013 | 
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 | 
| International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMSUDL 7,178,1987 | 
| International Agency for Research on Cancer (IARC) | Cancer Review:Animal NO EVIDENCE | IMEMDT 22,55,1980 | 
| International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMSUDL 22,55,1980 | 
| International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMSUDL 7,178,1987 | 
| TOXICOLOGY REVIEW | MUREAV 39,1,1976 | |
| TOXICOLOGY REVIEW | NBREV* 17,313,1993 | 
Standards and Regulations
NIOSH Documentation and Surveillance
| Organization | Standard | Reference | 
|---|---|---|
| National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CYCLOHEXYLAMINE-air | 10H time-weighted average 10 ppm | NIOSH* DHHS #95-121,1995 | 
| National Occupational Exposure Survey 1983 | Hazard Code 84526; Number of Industries 83; Total Number of Facilities 4729; Number of Occupations 47; Total Number of Employees Exposed 64346; Total Number of Female Employees Exposed 2914 | |
| National Occupational Hazard Survey 1974 | Hazard Code 84526; Number of Industries 63; Total Number of Facilities 3468; Number of Occupations 25; Total Number of Employees Exposed 9450 | 
Status in Federal Agencies
- Page last reviewed:March 7, 2014
 - Page last updated:February 6, 2017
 - Content source:
									
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division
 
 
ShareCompartir